BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16257399)

  • 1. Review: Collagen markers in early arthritic diseases.
    Elsaid KA; Chichester CO
    Clin Chim Acta; 2006 Mar; 365(1-2):68-77. PubMed ID: 16257399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical usefulness of the measurement of type-II procollagen carboxypeptide (C-II propeptide, pColl-II-C) in synovial fluid as a marker of collagen metabolism in cartilage].
    Shinmei M; Nagaya I; Miyanaga Y; Iwata H; Yamamoto S; Torisu T; Fujii K; Fukubayashi T; Kondo M; Kurosaka M
    Ryumachi; 1992 Oct; 32(5):453-60. PubMed ID: 1440081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding characteristics of antitype II collagen antibody to the surface of diseased human cartilage as a probe for tissue damage.
    Noyori K; Koshino T; Takagi T; Okamoto R; Jasin HE
    J Rheumatol; 1994 Feb; 21(2):293-6. PubMed ID: 8182639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telopeptides as markers of bone turnover in rheumatoid arthritis and osteoarthritis.
    Wong PK; Young L; Vaile JH; Tan L; Bertouch JV; Bleasel JF; White C
    Intern Med J; 2004; 34(9-10):539-44. PubMed ID: 15482266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis.
    Kong SY; Stabler TV; Criscione LG; Elliott AL; Jordan JM; Kraus VB
    Arthritis Rheum; 2006 Aug; 54(8):2496-504. PubMed ID: 16868970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of etanercept on serum biochemical markers of cartilage metabolism in patients with spondyloarthropathy.
    Briot K; Roux C; Gossec L; Charni N; Kolta S; Dougados M; Garnero P
    J Rheumatol; 2008 Feb; 35(2):310-4. PubMed ID: 18203315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [T cell proliferative response and antibody formation to citrullinated collagen type II in patients with rheumatoid arthritis].
    Tian X; Zhao Y; Li ZG
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):673-6. PubMed ID: 19595060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
    Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
    Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritis.
    Rousseau JC; Zhu Y; Miossec P; Vignon E; Sandell LJ; Garnero P; Delmas PD
    Osteoarthritis Cartilage; 2004 Jun; 12(6):440-7. PubMed ID: 15135140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of type IX collagen in osteoarthritis and rheumatoid arthritis.
    Diab M
    Orthop Rev; 1993 Feb; 22(2):165-70. PubMed ID: 8451069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy.
    Jansen NW; Roosendaal G; Lundin B; Heijnen L; Mauser-Bunschoten E; Bijlsma JW; Theobald M; Lafeber FP
    Arthritis Rheum; 2009 Jan; 60(1):290-8. PubMed ID: 19116938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and clinical application in arthritis of a new immunoassay for serum type IIA procollagen NH2 propeptide.
    Rousseau JC; Sandell LJ; Delmas PD; Garnero P
    Methods Mol Med; 2004; 101():25-37. PubMed ID: 15299208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High CCL18/PARC expression in articular cartilage and synovial tissue of patients with rheumatoid arthritis.
    Momohara S; Okamoto H; Iwamoto T; Mizumura T; Ikari K; Kawaguchi Y; Takeuchi M; Kamatani N; Tomatsu T
    J Rheumatol; 2007 Feb; 34(2):266-71. PubMed ID: 17304652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transition of healthy to diseased synovial tissue in rheumatoid arthritis is associated with gain of mesenchymal/fibrotic characteristics.
    Steenvoorden MM; Tolboom TC; van der Pluijm G; Löwik C; Visser CP; DeGroot J; Gittenberger-DeGroot AC; DeRuiter MC; Wisse BJ; Huizinga TW; Toes RE
    Arthritis Res Ther; 2006; 8(6):R165. PubMed ID: 17076892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New serum biochemical markers (Coll 2-1 and Coll 2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis.
    Deberg M; Labasse A; Christgau S; Cloos P; Bang Henriksen D; Chapelle JP; Zegels B; Reginster JY; Henrotin Y
    Osteoarthritis Cartilage; 2005 Mar; 13(3):258-65. PubMed ID: 15727893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential association of the N-propeptide of collagen IIA (PIIANP) and collagen II C-telopeptide (CTX-II) with synovitis and erosions in early and longstanding rheumatoid arthritis.
    Christensen AF; Lottenburger T; Lindegaard H; Christgau S; Hørslev-Petersen K; Junker P
    Clin Exp Rheumatol; 2009; 27(2):307-14. PubMed ID: 19473573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed joint.
    Nissim A; Winyard PG; Corrigall V; Fatah R; Perrett D; Panayi G; Chernajovsky Y
    Arthritis Rheum; 2005 Dec; 52(12):3829-38. PubMed ID: 16329077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological markers in osteoarthritis.
    Rousseau JC; Delmas PD
    Nat Clin Pract Rheumatol; 2007 Jun; 3(6):346-56. PubMed ID: 17538566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.